Clinical conditions and echocardiographic parameters associated with mortality in COVID‐19

Coronavirus disease 2019 (COVID‐19) is a recently recognized viral infective disease which can be complicated by acute respiratory stress syndrome (ARDS) and cardiovascular complications including severe arrhythmias, acute coronary syndromes, myocarditis and pulmonary embolism. The aim of the present study was to identify the clinical conditions and echocardiographic parameters associated with in‐hospital mortality in COVID‐19.

[1]  F. Asch,et al.  Echocardiographic Correlates of In-Hospital Death in Patients with Acute COVID-19 Infection: The World Alliance Societies of Echocardiography (WASE-COVID) Study , 2021, Journal of the American Society of Echocardiography.

[2]  G. De Luca,et al.  Cardiovascular risk factors and mortality in hospitalized patients with COVID-19: systematic review and meta-analysis of 45 studies and 18,300 patients , 2021, BMC Cardiovascular Disorders.

[3]  G. Galasso,et al.  Pulmonary embolism in COVID-19 patients: Prevalence, predictors and clinical outcome. , 2020, Thrombosis research.

[4]  G. Pontone,et al.  Role of multimodality imaging in evaluation of cardiovascular involvement in COVID-19 , 2020, Trends in Cardiovascular Medicine.

[5]  M. Ciccarelli,et al.  Timing of national lockdown and mortality in COVID-19: The Italian experience , 2020, International Journal of Infectious Diseases.

[6]  A. Silverio,et al.  Clinical characteristics and prognosis of hospitalized COVID‐19 patients with incident sustained tachyarrhythmias: A multicenter observational study , 2020, European journal of clinical investigation.

[7]  G. Parodi,et al.  Dual antiplatelet therapy in patients with acute coronary syndrome during the coronavirus disease of 2019 pandemia: the right choice at the right time. , 2020, Journal of cardiovascular medicine.

[8]  A. Scandroglio,et al.  Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19 , 2020, Heart.

[9]  R. Cocchia,et al.  Right Ventricular Function and Pulmonary Pressures as Independent Predictors of Survival in Patients With COVID-19 Pneumonia , 2020, JACC: Cardiovascular Imaging.

[10]  M. Gawaz,et al.  Impaired cardiac function is associated with mortality in patients with acute COVID-19 infection , 2020, Clinical Research in Cardiology.

[11]  E. Argulian,et al.  Echocardiographic Findings in Patients with COVID-19 with Significant Myocardial Injury , 2020, Journal of the American Society of Echocardiography.

[12]  C. Lodigiani,et al.  Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: A multicenter observational study , 2020, Pharmacological Research.

[13]  R. Steeds,et al.  Echocardiographic Findings in Patients With COVID-19 Pneumonia , 2020, Canadian Journal of Cardiology.

[14]  P. Ponikowski,et al.  Management of heart failure patients with COVID‐19: a joint position paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology , 2020, European journal of heart failure.

[15]  S. Solomon,et al.  COVID‐19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease , 2020, European journal of heart failure.

[16]  Thomas Song,et al.  Acute Pulmonary Embolism and COVID-19 , 2020, Radiology.

[17]  C. Specchia,et al.  Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy , 2020, European heart journal.

[18]  G. Parodi,et al.  The tug-of-war between coagulopathy and anticoagulant agents in patients with COVID-19 , 2020, European heart journal. Cardiovascular pharmacotherapy.

[19]  Eun Ji Kim,et al.  Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. , 2020, JAMA.

[20]  G. Pontone,et al.  COVID-19 pandemic and cardiac imaging: EACVI recommendations on precautions, indications, prioritization, and protection for patients and healthcare personnel , 2020, European heart journal cardiovascular Imaging.

[21]  M. Swaminathan,et al.  ASE Statement on Protection of Patients and Echocardiography Service Providers During the 2019 Novel Coronavirus Outbreak , 2020, Journal of the American College of Cardiology.

[22]  Mohammad Madjid,et al.  Potential Effects of Coronaviruses on the Cardiovascular System: A Review. , 2020, JAMA cardiology.

[23]  Roberto Maroldi,et al.  Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). , 2020, JAMA cardiology.

[24]  Ke Ma,et al.  Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study , 2020, BMJ.

[25]  W. Gong,et al.  Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. , 2020, JAMA cardiology.

[26]  Allan Schwartz,et al.  COVID-19 and Cardiovascular Disease , 2020, Circulation.

[27]  Victoria Ng,et al.  Estimation of COVID-19 outbreak size in Italy , 2020, The Lancet Infectious Diseases.

[28]  Lisa Rosenbaum,et al.  Facing Covid-19 in Italy - Ethics, Logistics, and Therapeutics on the Epidemic's Front Line. , 2020, The New England journal of medicine.

[29]  Xin Zhou,et al.  Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China , 2020, The Journal of Emergency Medicine.

[30]  Yan Zhao,et al.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.

[31]  Z. Memish,et al.  The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China , 2020, International Journal of Infectious Diseases.

[32]  Furio Colivicchi,et al.  ANMCO POSITION PAPER: Considerations on in-hospital cardiological consultations and cardiology outpatient clinics during the COVID-19 pandemic , 2020, European Heart Journal, Supplement.

[33]  Yaiza Beatriz Molero-Díez,et al.  Fourth universal definition of myocardial infarction , 2019, Colombian Journal of Anesthesiology.

[34]  Kristian Thygesen,et al.  Fourth Universal Definition of Myocardial Infarction (2018). , 2018, Journal of the American College of Cardiology.

[35]  B. Gerber,et al.  Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: an expert consensus document of the European Association of Cardiovascular Imaging , 2017, European heart journal cardiovascular Imaging.

[36]  A. Silverio,et al.  Clinical imaging in patients experiencing chest pain. , 2017, Minerva cardioangiologica.

[37]  Yuchi Han,et al.  Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. , 2017, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[38]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, European heart journal cardiovascular Imaging.

[39]  Arthur S Slutsky,et al.  Acute Respiratory Distress Syndrome The Berlin Definition , 2012 .

[40]  D. Moher,et al.  A catalogue of reporting guidelines for health research , 2010, European journal of clinical investigation.

[41]  S. Solomon,et al.  Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. , 2005, The New England journal of medicine.

[42]  W. Grimm,et al.  Noninvasive Arrhythmia Risk Stratification in Idiopathic Dilated Cardiomyopathy: Results of the Marburg Cardiomyopathy Study , 2003, Circulation.